Leerink Partners Maintains Outperform on Tenet Healthcare, Raises Price Target to $342

Benzinga · 1d ago
Leerink Partners analyst Whit Mayo maintains Tenet Healthcare (NYSE:THC) with a Outperform and raises the price target from $309 to $342.